These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34242002)

  • 21. Synthesis of 3,4-dihydro-2H-1,2,4-benzo-thiadiazine 1,1-dioxide derivatives as potential allosteric modulators of AMPA/kainate receptors.
    Braghiroli D; Puia G; Cannazza G; Tait A; Parenti C; Losi G; Baraldi M
    J Med Chem; 2002 Jun; 45(12):2355-7. PubMed ID: 12036344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds.
    Drapier T; Geubelle P; Bouckaert C; Nielsen L; Laulumaa S; Goffin E; Dilly S; Francotte P; Hanson J; Pochet L; Kastrup JS; Pirotte B
    J Med Chem; 2018 Jun; 61(12):5279-5291. PubMed ID: 29775064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel dualistic profile of an allosteric AMPA receptor modulator identified through studies on recombinant receptors, mouse hippocampal synapses and crystal structures.
    Christiansen GB; Harbak B; Hede SE; Gouliaev AH; Olsen L; Frydenvang K; Egebjerg J; Kastrup JS; Holm MM
    Neuroscience; 2015 Dec; 310():709-22. PubMed ID: 26450748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative allosteric modulators of AMPA-preferring receptors inhibit [(3)H]GABA release in rat striatum.
    Harsing LG; Csillik-Perczel V; Ling I; Sólyom S
    Neurochem Int; 2000 Jul; 37(1):33-45. PubMed ID: 10781843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A charge-inverting mutation in the "linker" region of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors alters agonist binding and gating kinetics independently of allosteric modulators.
    Harms JE; Benveniste M; Kessler M; Stone LM; Arai AC; Partin KM
    J Biol Chem; 2014 Apr; 289(15):10702-10714. PubMed ID: 24550387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
    Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
    Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Arylbenzothiadiazine Type Compounds as Positive Allosteric Modulators of AMPA/Kainate Receptors.
    Battisti UM; Jozwiak K; Cannazza G; Puia G; Stocca G; Braghiroli D; Parenti C; Brasili L; Carrozzo MM; Citti C; Troisi L
    ACS Med Chem Lett; 2012 Jan; 3(1):25-9. PubMed ID: 24900368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, stereoselective synthesis, configurational stability and biological activity of 7-chloro-9-(furan-3-yl)-2,3,3a,4-tetrahydro-1H-benzo[e]pyrrolo[2,1-c][1,2,4]thiadiazine 5,5-dioxide.
    Carrozzo MM; Battisti UM; Cannazza G; Puia G; Ravazzini F; Falchicchio A; Perrone S; Citti C; Jozwiak K; Braghiroli D; Parenti C; Troisi L
    Bioorg Med Chem; 2014 Sep; 22(17):4667-76. PubMed ID: 25126714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxylated analogues of ATP-sensitive potassium channel openers belonging to the group of 6- and/or 7-substituted 3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides: toward an improvement in sulfonylurea receptor 1 selectivity and metabolism stability.
    de Tullio P; Servais AC; Fillet M; Gillotin F; Somers F; Chiap P; Lebrun P; Pirotte B
    J Med Chem; 2011 Dec; 54(24):8353-61. PubMed ID: 22077416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors.
    Stenum-Berg C; Musgaard M; Chavez-Abiega S; Thisted CL; Barrella L; Biggin PC; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):835-850. PubMed ID: 31582576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depolarization-induced release of [(3)H]D-aspartate from GABAergic neurons caused by reversal of glutamate transporters.
    Jensen JB; Pickering DS; Schousboe A
    Int J Dev Neurosci; 2000; 18(2-3):309-15. PubMed ID: 10715585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,2,4-Benzothiadiazine-1,1-dioxide derivatives as ionotropic glutamate receptor ligands: synthesis and structure-activity relationships.
    Varano F; Catarzi D; Colotta V; Squarcialupi L; Matucci R
    Arch Pharm (Weinheim); 2014 Nov; 347(11):777-85. PubMed ID: 25204434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.
    Ahmed AH; Ptak CP; Oswald RE
    Biochemistry; 2010 Apr; 49(13):2843-50. PubMed ID: 20199107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
    Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G
    J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of a negative allosteric modulator and competitive antagonist can occur simultaneously at the ionotropic glutamate receptor GluA2.
    Krintel C; Dorosz J; Larsen AH; Thorsen TS; Venskutonytė R; Mirza O; Gajhede M; Boesen T; Kastrup JS
    FEBS J; 2021 Feb; 288(3):995-1007. PubMed ID: 32543078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics and allosteric potential of the AMPA receptor N-terminal domain.
    Sukumaran M; Rossmann M; Shrivastava I; Dutta A; Bahar I; Greger IH
    EMBO J; 2011 Mar; 30(5):972-82. PubMed ID: 21317871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional insight into development of positive allosteric modulators of AMPA receptors.
    Weeks AM; Harms JE; Partin KM; Benveniste M
    Neuropharmacology; 2014 Oct; 85():57-66. PubMed ID: 24878241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling studies, synthesis, configurational stability and biological activity of 8-chloro-2,3,5,6-tetrahydro-3,6-dimethyl-pyrrolo[1,2,3-de]-1,2,4-benzothiadiazine 1,1-dioxide.
    Battisti UM; Carrozzo MM; Cannazza G; Puia G; Troisi L; Braghiroli D; Parenti C; Jozwiak K
    Bioorg Med Chem; 2011 Dec; 19(23):7111-9. PubMed ID: 22019464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
    Bourasset F; Bernard K; Muñoz C; Genissel P; Scherrmann JM
    Drug Metab Dispos; 2005 Aug; 33(8):1137-43. PubMed ID: 15860654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation.
    Timm DE; Benveniste M; Weeks AM; Nisenbaum ES; Partin KM
    Mol Pharmacol; 2011 Aug; 80(2):267-80. PubMed ID: 21543522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.